Recombine
AcquiredNew York, US · Founded 2011 · 3 known investors
Find your way into Recombine
Sign up to see every warm intro you have to Recombine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Recombine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by CooperSurgical (The Cooper Companies) May 2016 · $85M (approximately $85 million) · source ↗
Recombine was a New York-based clinical genetics company offering expanded carrier screening (CarrierMap) and non-invasive prenatal testing (ChromoMap) to assess genetic and chromosomal risks for prospective parents.
Founders & leadership
Recombine was founded in 2011 by Alexander Bisignano.
Board

Investors · 3
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2014–2015
▶$995KraisedOct 2015 · 10 investors · Other TechnologyRule 506(b)
- Alexander BisignanoExecutive Officer, Director
- Mathias TurckDirector
- Santiago MunneDirector
- Offering amount
- $1M
- Amount sold
- $995K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$3.6MraisedFeb 2014 · 13 investors · Other TechnologyRule 506(b)
- Mathias TurckDirector
- Santiago MunneExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Recombine went on to found or lead other companies.
In the news
Frequently asked questions
- What does Recombine do?
- Recombine was a New York-based clinical genetics company offering expanded carrier screening (CarrierMap) and non-invasive prenatal testing (ChromoMap) to assess genetic and chromosomal risks for prospective parents.
- Who founded Recombine?
- Recombine was founded by Alexander Bisignano in 2011.
- Who are Recombine's investors?
- Recombine's investors include FirstMark Capital, Nat Turner, Vast Ventures.
- How much funding has Recombine raised?
- Recombine has disclosed $4.6M raised across 2 rounds.
- Where is Recombine headquartered?
- Recombine is headquartered in New York, US.


